185 related articles for article (PubMed ID: 14687413)
1. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.
Padalko E; Verbeken E; Matthys P; Aerts JL; De Clercq E; Neyts J
BMC Microbiol; 2003 Dec; 3():25. PubMed ID: 14687413
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of coxsackie B3 virus induced myocarditis in mice by 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile.
Padalko E; Verbeken E; De Clercq E; Neyts J
J Med Virol; 2004 Feb; 72(2):263-7. PubMed ID: 14695668
[TBL] [Abstract][Full Text] [Related]
3. The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis.
Padalko E; Nuyens D; De Palma A; Verbeken E; Aerts JL; De Clercq E; Carmeliet P; Neyts J
Antimicrob Agents Chemother; 2004 Jan; 48(1):267-74. PubMed ID: 14693549
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis.
Kamiyoshi Y; Takahashi M; Yokoseki O; Yazaki Y; Hirose S; Morimoto H; Watanabe N; Kinoshita O; Hongo M; Ikeda U
J Mol Cell Cardiol; 2005 Sep; 39(3):467-77. PubMed ID: 15978615
[TBL] [Abstract][Full Text] [Related]
6. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice.
Shim SH; Park JH; Ye MB; Nam JH
Acta Virol; 2013; 57(4):462-6. PubMed ID: 24294962
[TBL] [Abstract][Full Text] [Related]
8. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.
Kishimoto C; Crumpacker CS; Abelmann WH
Cardiovasc Res; 1988 Oct; 22(10):732-8. PubMed ID: 2855719
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study on effect of xinkang oral liquid on coxsackie B3 viral myocarditis in mice].
Zhao H; Wan SJ; Xu XL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):277-9. PubMed ID: 12577357
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis.
Fohlman J; Pauksen K; Hyypiä T; Eggertsen G; Ehrnst A; Ilbäck NG; Friman G
Circulation; 1996 Nov; 94(9):2254-9. PubMed ID: 8901680
[TBL] [Abstract][Full Text] [Related]
14. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.
Weiss LM; Movahed LA; Billingham ME; Cleary ML
Am J Pathol; 1991 Feb; 138(2):497-503. PubMed ID: 1847008
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sophora flavescens Ait on cultured beating myocardial cells of coxsackie B3 virus infected newborn rat.
Chen S; Peng X; Liu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):137-40. PubMed ID: 11503044
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice].
Wan SJ; Yang F; Huang XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932
[TBL] [Abstract][Full Text] [Related]
18. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
19. Myocarditis: an expected health hazard associated with water resources contaminated with Coxsackie viruses type B.
Ali MA; Abdel-Dayem TM
Int J Environ Health Res; 2003 Sep; 13(3):261-70. PubMed ID: 12909557
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide influences viral replication in target organs of coxsackievirus B3-infected mice.
Molin Y; Frisk P; Hjelm E; Blomberg J; Friman G; Ilbäck NG
Microbes Infect; 2010 Nov; 12(12-13):1027-34. PubMed ID: 20638482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
